Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic, epigenomic and transcriptomic landscape of glioblastoma.

Metabolic brain disease - 1 Dec 2024

Dakal Tikam Chand, Kakde Ganesh S, Maurya Pawan Kumar

Abstract excerpt

The mostly aggressive and extremely malignant type of central nervous system is Glioblastoma (GBM), which is characterized by an extremely short average survival time of lesser than 16 months. The primary cause of this phenomenon can be attributed to the extensively altered genome of GBM, which is characterized by the dysregulation of numerous critical signaling pathways and epigenetics regulations associated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Epigenesis, Genetic
Share to Epigenomics

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Genomics

Share to Glioblastoma

Share to Signal Transduction

Share to Transcriptome

Source

Identifiers

PMID: 39180605
DOI: 10.1007/s11011-024-01414-8

Genes

CDKN2A
IDH1
MGMT
STAT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic, epigenomic and transcriptomic landscape of glioblastoma.PMID 39180605Read ↗

Glioblastoma: An Update in Pathology, Molecular Mechanisms and BiomarkersSemantic proximity Read ↗

An Update on the Epigenetics of GlioblastomasSemantic proximity Read ↗

GLIOBLASTOMA MULTIFORME: A META-ANALYSIS OF DRIVER GENES, CURRENT DIAGNOSIS, AND TUMOR HETEROGENEITYSemantic proximity Read ↗

An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatmentSemantic proximity Read ↗

Key genes altered in glioblastoma based on bioinformatics (Review)Semantic proximity Read ↗

Molecular Pathogenesis and Emerging Treatment for Glioblastoma.Semantic proximity Read ↗

Understanding the Genomic Landscape of Glioblastoma: Opportunities for Targeted TherapiesSemantic proximity Read ↗

Glioblastoma multiforme: a multi-omics analysis of driver genes and tumour heterogeneitySemantic proximity Read ↗

Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.Semantic proximity Read ↗

Molecular and Genomic Alterations in Glioblastoma Multiforme.Semantic proximity Read ↗

Genetic and signaling pathway alterations in glioblastoma: relevance to novel targeted therapies.Semantic proximity Read ↗

Epigenetic dysregulation in glioblastoma: potential pathways to precision medicine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.